republic-os/legislation/us/states/de/150/sb-34.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE CREATING A PRESCRIPTION OPIOID IMPACT FUND.	This Act creates a Prescription Opioid Impact Fund (“Fund”) through a prescription opioid impact fee (“Fee”) that is paid by pharmaceutical manufacturer. The anticipated revenue from the Fee is $2.8 million in 2020, $2.7 million in 2021, and $2.5 million in 2022.:	us/states/de	Delaware General Assembly	150	SB 34	Delaware SB 34 (150)	bill		enacted	Anthony Delcollo David Bentz Kevin S Hensley Stephanie L. Hansen	2	8	2	2019-03-12	2019-06-12	openstates	ocd-bill/57812ec9-b41c-4cf5-b7d0-6b7d8c061ca5	https://legis.delaware.gov/BillDetail?LegislationId=47187	8b766578c266b2a78c3a405a351d4a3a694897b238e6c474ffcd96ef7fe47af6	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-de

Delaware SB 34 (150) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE CREATING A PRESCRIPTION OPIOID IMPACT FUND.

This Act creates a Prescription Opioid Impact Fund (“Fund”) through a prescription opioid impact fee (“Fee”) that is paid by pharmaceutical manufacturer. The anticipated revenue from the Fee is $2.8 million in 2020, $2.7 million in 2021, and $2.5 million in 2022.:

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Bill Text (committee substitute) — source
2. SA 1 to SB 34 (committee substitute) — source

Votes

• 3/5 — 33–8 (pass) · lower
• 3/5 — 17–4 (pass) · upper

Sponsors

• Anthony Delcollo — primary (person)
• David Bentz — primary (person)
• Kevin S Hensley — primary (person)
• Stephanie L. Hansen — primary (person)
• Bruce C. Ennis — cosponsor (person)
• Bryan Townsend — cosponsor (person)
• David B. McBride — cosponsor (person)
• David P. Sokola — cosponsor (person)
• Debra Heffernan — cosponsor (person)
• Edward S. Osienski — cosponsor (person)
• Gerald L. Brady — cosponsor (person)
• Harris B. McDowell — cosponsor (person)
• John "Jack" Walsh — cosponsor (person)
• Kimberly Williams — cosponsor (person)
• Laura V. Sturgeon — cosponsor (person)
• Michael F. Smith — cosponsor (person)
• Nicole Poore — cosponsor (person)
• Paul S. Baumbach — cosponsor (person)
• Raymond Seigfried — cosponsor (person)
• S. Elizabeth Lockman — cosponsor (person)
• Sherry Dorsey Walker — cosponsor (person)
• Trey Paradee — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2019-03-12 Introduced and Assigned to Health & Social Services Committee in Senate introduction, referral-committee
• 2019-03-27 Reported Out of Committee (Health & Social Services) in Senate with 1 Favorable, 3 On Its Merits committee-passage-favorable, committee-passage
• 2019-04-09 Amendment SA 1 to SB 34 - Passed By Senate. Votes: 19 YES 2 NO amendment-passage
• 2019-04-09 Passed By Senate. Votes: 17 YES 4 NO passage
• 2019-04-11 Assigned to Health & Human Development Committee in House introduction, referral-committee
• 2019-05-08 Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 6 On Its Merits committee-passage-favorable, committee-passage
• 2019-05-16 Passed By House. Votes: 33 YES 8 NO passage
• 2019-06-12 Signed by Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/57812ec9-b41c-4cf5-b7d0-6b7d8c061ca5. Confidence: reported (aggregated from official Delaware legislature records).